Dear Colleagues! This is Asrar Qureshi’s Blog Post #1340 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com for publishing your contributions here.



How Can Pharmaceutical Companies Bridge the Gap?
The solution requires a shift from departmental management to integrated business management. The following approaches can make a meaningful difference.
Develop Strategy Collectively
Strategy should not be the exclusive responsibility of the commercial department. Once the broad corporate direction is established, all functional heads should participate in translating it into an executable business plan.
For example, if the strategic objective is to grow a therapeutic segment by 20%, the implications should be discussed collectively:
Sales: What field-force capabilities and coverage are required?
Marketing: What brand investments and customer engagement programmes are needed?
Supply chain: What production capacity and inventory levels are necessary?
Finance: What investment is justified, and what return is expected?
HR: What recruitment and capability development are required?
IT: What data and technology support will be needed?
This creates collective ownership.
Introduce Shared Corporate KPIs
Departmental KPIs should not operate independently of corporate goals. Companies should establish a set of common performance indicators that require departments to work together.
Examples include:
Revenue growth – Sales, marketing, supply chain and finance
Product availability – Supply chain, manufacturing, procurement and sales
Gross margin improvement – Finance, procurement, manufacturing and commercial
New product launch performance – Marketing, regulatory, manufacturing, supply chain and sales
Forecast accuracy – Sales, marketing, finance and supply chain
Customer satisfaction – Sales, distribution, supply chain and customer service
This does not mean every department should have identical KPIs. It means that individual departmental targets should support shared organisational outcomes.
Establish Cross-functional Business Reviews
Many organisations hold departmental review meetings but lack effective cross-functional reviews. A monthly business performance meeting should bring together the CEO and all functional heads. Its purpose should be to discuss:
- Progress against corporate growth targets.
- Sales and market-share performance.
- Product availability and stock shortages.
- Forecast accuracy and inventory levels.
- Budget utilisation and profitability.
- New product launch progress.
- Decisions and resource constraints requiring management intervention.
The discussion should focus on resolving business issues rather than explaining why a particular department has not achieved its targets.
Replace Blanket Cost-cutting with Value-based Resource Allocation
Finance should help the organisation distinguish between productive and unproductive expenditure.
Instead of asking, “How much can we cut from the marketing budget?”, management should ask: “Which investments will generate the highest sustainable return?” This requires better business cases, financial analysis and post-investment evaluation. A promotional programme that generates profitable market growth deserves a different treatment from one that produces little measurable value.
Similarly, maintaining additional inventory may be justified for strategically important products if the cost of stockholding is lower than the potential commercial and patient-service consequences of stockouts.
Financial discipline should improve the quality of investment decisions, not automatically restrict them.
Introduce rolling forecasts and flexible budgets
Annual budgets provide direction, but they should not become barriers to responding to changing market conditions.
Pharmaceutical companies should consider quarterly rolling forecasts, scenario planning and periodic resource reallocation. If a product is growing faster than expected, resources may need to be shifted towards it. If a product is underperforming, expenditure may need to be reduced. If a new market opportunity emerges, the organisation should have a mechanism for evaluating and funding it. This approach combines financial control with commercial agility.
Make support functions accountable for business outcomes
Finance should not be judged only on budget compliance. It should also be assessed on the quality and speed of financial support to business decisions.
Supply chain should not be evaluated only on inventory reduction. Product availability and service levels must also matter.
HR should not be judged merely on controlling manpower costs. Its contribution to workforce productivity, retention and capability development should be measured.
The objective is to transform support departments from internal service providers into strategic business partners.
Change the behaviour of senior leadership
No organisational system can overcome conflicting leadership behaviour.
If the CEO talks about growth but rewards only cost reduction, the organisation will prioritise cost reduction. If the CEO encourages collaboration but allows departmental heads to blame one another, silos will persist. If senior management approves ambitious strategies without committing the necessary resources, employees will eventually stop taking strategic plans seriously. Leadership must demonstrate that corporate objectives take precedence over departmental interests.
A practical example: Aligning the organisation around a new product launch
Consider a pharmaceutical company planning to launch a new product in a competitive therapeutic segment. A traditional approach might involve marketing developing the launch plan, sales receiving targets and support departments being asked to provide resources.
An integrated approach would be different.
- Marketing: Market assessment, positioning, launch strategy and promotional planning
- Sales: Customer coverage, field-force readiness and launch execution
- Regulatory: Registration, approvals and compliance
- Manufacturing: Production planning, capacity and quality assurance
- Supply chain: Inventory planning and distribution readiness
- Finance: Investment appraisal, cash-flow planning and profitability analysis
- HR: Recruitment, training and incentive alignment
- IT: Reporting systems, analytics and digital support
A cross-functional launch team should be established with a clearly designated leader, milestones, responsibilities and measurable targets. The launch should be reviewed regularly, and problems should be resolved collectively. This approach reduces the possibility of marketing promising what manufacturing cannot deliver or sales pursuing targets without adequate product availability. Most importantly, it makes everyone responsible for the success of the launch.
The CEO’s role: Become the chief integrator
The CEO must recognise that the organisation’s most important responsibility is not to maximise the performance of individual departments. It is to maximise the performance of the company as a whole. This requires the CEO to act as the chief integrator of organisational priorities.
The CEO should:
- Communicate a clear and consistent corporate strategy.
- Ensure that all departments understand how they contribute to it.
- Resolve conflicts between commercial ambition and resource constraints.
- Establish shared performance measures.
- Encourage constructive challenge and collaboration.
- Hold functional heads collectively accountable for results.
A particularly useful practice is to ask every functional head a simple question during management reviews: “What have you done this month to help the company achieve its strategic priorities?” This question changes the focus from departmental activity to corporate contribution.
Sum Up
A pharmaceutical company cannot achieve sustainable growth without financial discipline. Equally, it cannot achieve growth by allowing cost control to become the dominant organisational philosophy.
The two objectives are not contradictory. Good financial management makes growth sustainable. An effective supply chain enables commercial success. Strong HR capabilities improve productivity. Technology strengthens decision-making. And commercial ambition provides the direction towards which all these functions should contribute. The challenge is to create an organisation in which every department understands that its success depends on the success of the whole company.
The ultimate competitive advantage does not come from having the best strategy or the most efficient departments. It comes from having an organisation in which strategy, resources, capabilities and execution move in the same direction.
Concluded.
Disclaimers: Pictures in these blogs are taken from free resources at Pexels, Pixabay, Unsplash, and Google. Credit is given where available. If a copyright claim is lodged, we shall remove the picture with appropriate regrets.
For most blogs, I research from several sources which are open to public. Their links are mentioned under references. There is no intent to infringe upon anyone’s copyrights. If, any claim is lodged, it will be acknowledged and duly recognized immediately.







